Francois-Melchior De Poulignac Presentation CEO & Director Thank you. Good evening, everyone, and thank you for joining us today for Maisons du Monde's third quarter 2025 results. Obviously, this quarter brings us some level of satisfaction as we post positive figures. Yet this comes on a very negative historical basis, of course. What really is key to us is that we keep moving forward in our in-depth transformation throughout the company from its basement to its roof. Without covering all our strategic pro ...

Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a technical analyst for Dow Jones Newswires and as the senior market analyst with TraderPlanet.com. Jim is also a consultant with the highly respected "Pro Farmer" agricultural advisory service. Jim was also the head equities analyst at CapitalistEdge.com. He received his degree from Iowa State University in Ames, Iowa, where he studied journalism and economics. Follow Jim daily ...

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or ...

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Grindr Inc.'s (NYSE: GRND) board of directors and majority stockholders James Fu Bin Lu and George Raymond Zage, III, for potential breaches of their fiduciary duties to shareholders in connection with a potential take-private sale of Grindr that would cash out the entire minority stockholder interest. Why is Grindr being Investigated? All representation is on a contingency fee ...

Accessibility StatementSkip Navigation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? HONG KONG, Oct. 24, 2025 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC), a diversified investment holding company with subsidiaries engaged in logistics, warehousing, and consulting services, has announced its unaudited financial highlights for the first two quarters of 2025, showing remarkable year-over-year growth. For the first quarter of 2025, the Group recorded a 138% increase in revenue and a 158% increase in gross ...

Why is Guess being Investigated? NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Guess?, Inc.'s (NYSE: GES) board of directors and executive officers for potential breaches of their fiduciary duties to shareholders in connection with its pending sale to Authentic Brands Group LLC ("Authentic") for $16.75 per share. If you are a current shareholder of Guess, you are encouraged to obtain additional information by visiting: http ...

PresentationYasuaki OkadaGeneral Manager of IR Group Hi, everybody. I'm Okada, General Manager of IR Group, and I'll be the host for today's webinar. Thanks for joining us, and we truly appreciate your time and interest. Today's webinar is all about next-generation marine fuel, business opportunities arising from this transition and NYK strategy in this transition. We hope you will find the session informative. First, I'd like to introduce our speaker, Mr. Rokuroda, General Manager of Next-Generation Fuel B ...

The cybersecurity company CrowdStrike Holdings Inc. (NASDAQ: CRWD) recently saw record attendance at its Fal.Con 2025 conference, and it unveiled a major update to its Falcon platform. ...

Join Now to Access Our Top Picks for November 2025!Your timing is perfect! We’ve just released our latest top investment picks, and by joining today, you’ll gain immediate access to these exciting opportunities. We invest thousands of hours and over $100,000 annually into researching the most profitable investment opportunities—all to bring you high-yield strategies at just a fraction of the cost.Our approach has earned us 190+ five-star reviews from satisfied members who are already seeing the benefits. Do ...

My last coverage of Crispr Therapeutics (NASDAQ: CRSP ) and Intellia Therapeutics (NASDAQ: NTLA ) was published in May 2025 . At the time, gene therapy stocks were suffering from regulatory uncertainties, potential pricingOriginally a Biologist, M.Sc in Biomedicine, PhD in Bioengineering, with +20 years experience in the research and development of novel Cell & Gene Therapies (CGT) tackling several clinical needs. As an investor, I have been utilising my background in life sciences to assess the potential o ...